AndrewsG. A.: A treatment of pleural effusions with radioactive colloids. In: Therapeutic use of artificial radioisotopes, p. 295. Ed. HahnP. F.. Chapman & Hall, London 1956.
2.
CourticeF. C.SteinbeckA. W.: Absorption of protein from the peritoneal cavity. J. Physiol.114(1951), 336.
3.
DobsonE. L.: Factors controlling phagocytosis. In: Physio-pathology of the reticulo-endothelial system. Ed. HalpernB. N.. Blackwell Scient. Publ., Oxford 1957.
4.
EfskindL.: Experimentelle Untersuchungen über die Biologie des Peritoneums. Det Norske Videnskabsakademi, Oslo 1940.
5.
FriesB.: Polyphloretin phosphate — A hyaluronidase inhibitor — And hyaluronidase in prevention of intraperitoneal adhesions. Acta chir. scand. Suppl.217(1956).
6.
FriesB.WalinderG.: Absorption of colloidal Au198 from peritoneum and pleura and its inhibition by polyphloretin phosphate. Acta radiol.48(1957), 113.
7.
KrookH.: Circulatory studies in liver cirrhosis. Acta med. scand. Suppl.318(1956).
8.
MüllerJ. H.: Intraperitoneal application of radioactive colloids. In: Therapeutic use of artificial radioisotopes, p. 269. Ed. HahnP. F.. Chapman & Hall, London 1956.
9.
WalinderG.: Colloidal As276S3. Its production and possible use in the treatment of papillomatosis of the urinary bladderActa radiol.44(1955), 521.
10.
VetterH.FalknerR.NeumayrA.: Disappearance rate of colloidal radiogold from circulation and its application to estimation of liver blood flow in normal and cirrhotic subjects. J. Clin. Invest.33(1954), 1594.
11.
ZilversmitD. B.BoydG. A.BrucerM.: Effect of particle size on blood clearance and tissue distribution of radioactive colloids. J. Lab. clin. Med.40(1952), 255.